Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study.

Marzona I, Avanzini F, Lucisano G, Tettamanti M, Baviera M, Nicolucci A, Roncaglioni MC; Risk & Prevention Collaborative Group.

Acta Diabetol. 2017 Feb;54(2):123-131. doi: 10.1007/s00592-016-0899-0. Epub 2016 Oct 7.

PMID:
27718051
2.

n-3 fatty acids in patients with multiple cardiovascular risk factors.

Risk and Prevention Study Collaborative Group, Roncaglioni MC, Tombesi M, Avanzini F, Barlera S, Caimi V, Longoni P, Marzona I, Milani V, Silletta MG, Tognoni G, Marchioli R.

N Engl J Med. 2013 May 9;368(19):1800-8. doi: 10.1056/NEJMoa1205409. Erratum in: N Engl J Med. 2013 May 30;368(22):2146.

4.

[Cyclophosphamide, adriamycin and platinum (CAP) in the preoperative neoadjuvant phase and the therapy phase].

Cartei G, Marsilio P, Morandini G, Rosa Bian A, Clocchiati L, Galletti D, Sibau A, Cendron R, Cacciavillani C, Cantone A, et al.

Chir Ital. 1986 Oct;38(5):534-42. Italian.

PMID:
3815644

Supplemental Content

Loading ...
Support Center